Breaking news on erectile dysfunction premature ejaculation
New Penile Pump Could Improve Patient Satisfaction, Confidence published
Fri, 02 May 2008 01:00:00 PDT
Erectile dysfunction (ED) has a dramatic impact on quality of life. Treatments for ED continue to improve, and penile prostheses have one of the highest patient satisfaction rates. In the April 2008 issue of Urologic Nursing, Susanne A. Quallich, Dana A. Ohl and Rodney L. Dunn survey urologic health care practitioners to find the penile prosthesis pump that is easiest to use and teach to patients.
Teaching Patients To Use Their Penile Prosthesis Requires Compassion published
Fri, 02 May 2008 01:00:00 PDT
While penile prosthesis devices are the most invasive and least chosen treatments for erectile dysfunction (ED), the devices garner the highest patient satisfaction rates. In the April 2008 issue of Urologic Nursing, Annette Liechty and Susanne A. Quallich review a teaching process that nurses can use to show a patient to successfully operate the device.
Fewer Complications From Minimally Invasive Pancreas Surgery published
Mon, 28 Apr 2008 02:00:00 PDT
When surgeons need to remove part of the pancreas, performing the operation with minimally invasive techniques offers patients a shorter hospital stay and fewer complications, researchers have concluded.A study of more than 660 operations to remove pancreatic tumors and cysts over five years found that after laparoscopic surgery, patients stayed a third less time in the hospital without experiencing more complications such as leaks.
Correlation Between Erectile Dysfunction And LUTS The AUA Lecture published
Sat, 19 Apr 2008 00:00:00 PDT
UroToday.com - Dr. Kevin McVary (Chicago) presented the AUA lecture. The incidence of ED increases to over 60% by age 60. He showed data that ED increases with increasing severity of LUTS, independent of age. Across all age groups, increasing LUTS correlated with worse ED even after adjusting for other factors such as diabetes mellitus. This suggests a common pathophysiology or causal relationship between ED and LUTS.
Federal Authorities Seize More Than 100,000 Dollars Of Unapproved Drugs Marketed As "Natural Supplements" published
Thu, 10 Apr 2008 06:00:00 PDT
At the request of the U.S. Food and Drug Administration, U.S. Marshals seized more than 14,000 dosage units of Shangai Regular, Shangai Ultra, Super Shangai, Naturalë Super Plus, and Lady Shangai. Although labeled as natural supplements, the seized products were all marketed to treat erectile dysfunction (ED), impotency, and/or to provide sexual enhancement, which caused them to be drugs under the Federal Food, Drug, and Cosmetic Act.
VIVUS Enters Into 30 Million Dollars Funding Collaboration For The Phase 3 Studies Of Avanafil For Erectile Dysfunction published
Mon, 07 Apr 2008 03:00:00 PDT
VIVUS, Inc. (NASDAQ: VVUS) announced that it has entered into a $30 million funding collaboration with Deerfield Management ("Deerfield"). Under the terms of the agreements, Deerfield will provide funds for the phase 3 program for avanafil, a fast-acting, highly selective, phosphodiesterase type 5 inhibitor (PDE5i) for the treatment of erectile dysfunction (ED).
Levitra® Therapy Suitable For Men With High Cholesterol published
Sat, 05 Apr 2008 00:00:00 PDT
At the 23rd Annual European Association of Urology (EAU) Congress, results were presented which added evidence that Levitra® (vardenafil HCI) works very well in men with dyslipidemia.(1) The double-blind, placebo-controlled trial in about 400 men showed that Levitra® significantly improved the ability of men with erectile dysfunction (ED) and high cholesterol, to achieve and maintain an erection for successful sexual intercourse.(2) The trial, led by Dr.
Erection Hardness Scale Proves Effective In Assessing Erection Quality published
Fri, 28 Mar 2008 00:00:00 PDT
The Erection Hardness Scale (EHS), an easy-to-use, four-point scale for erectile dysfunction (ED), provides a reliable measure of erection hardness and an indicator of other health and wellbeing outcomes, according to new data reported at the European Association of Urology. EHS rates the hardness of erection on a scale of one to four, with four being the maximal score.
High Levels Of The Molecule Adenosine Linked To Priapism published
Fri, 14 Mar 2008 03:00:00 PDT
Priapism (prolonged penile erection in the absence of sexual interest) is common in male individuals with sickle cell disease (SCD), a blood disorder characterized by abnormally shaped red blood cells. Priapism is considered a medical emergency because it is associated with decreased blood flow to the erectile tissue, which can result in erectile tissue damage and, subsequently, erectile dysfunction and impotence.
Daily Vardenafil For 6 Months Has No Detrimental Effects On Semen Characteristics Or Reproductive Hormones In Men With Normal Baseline Levels published
Sat, 08 Mar 2008 00:00:00 PDT
UroToday.com - This a randomized, double-blind, placebo controlled, parallel group, multicenter study involving 200 men with or without erectile dysfunction. Men (25-64 years of age) did not have ejaculatory dysfunction. Subjects were randomized to daily treatment with vardenafil, sildenafil or placebo for 6 months. Baseline sperm concentrations were compared to specimens acquired after 6 months of placebo or treatment.
Two Men Fined For Selling Erectile Dysfunction Drugs, UK published
Thu, 14 Feb 2008 05:00:00 PDT
The Medicines and Healthcare products Regulatory Agency successfully prosecuted two men on 7 February 2008 at Bradford Magistrates Court for selling unlicensed medicines. David Tetley, (61) retired, and Stephen Evans, (49) unemployed, of 554 Leeds Road, Idle, Bradford, BD10 8JH, they pleaded guilty to the illegal sale and supply of Kamagra, Kamagra Oral Jelly and Loveagra.Tetley and Evans were advertising the drugs in 'Shout' a gay publication.
Cook Medical Launches Online Destination To Educate Physicians And Patients On A Leading Form Of Erectile Dysfunction published
Fri, 01 Feb 2008 02:00:00 PDT
Cook Medical , announced the launch of www.MensHealthPD.
Slough Man Sentenced To Community Service For Peddling Counterfeit Medicines, UK published
Mon, 14 Jan 2008 02:00:00 PDT
Mohammed Azim Dad (30) of 116 Chippenham Lane, Slough, SL1 5BA was sentenced to 250 hours community service on three counts under the Trade Marks Act 1994 relating to counterfeit erectile dysfunction medication, namely Viagra, Cialis and Levitra. Mr Dad appeared at Reading Crown Court following an investigation by the Medicines and Healthcare products Regulatory Agency (MHRA).
FDA Approves Cialis(R) (tadalafil) For Once Daily Use For The Treatment Of Erectile Dysfunction published
Wed, 09 Jan 2008 00:00:00 PDT
Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) has approved Cialis(R) (tadalafil)(1) for once daily use (2.5 mg and 5 mg), an oral medication taken once per day to treat erectile dysfunction (ED). When Cialis for once daily use is taken daily, men can attempt sexual activity at anytime between doses.
New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) In Men With Dyslipidemia, Including High Cholesterol published
Tue, 11 Dec 2007 00:00:00 PDT
Results of the first prospective trial specifically designed to evaluate erectile function in erectile dysfunction (ED) patients with dyslipidemia show that LEVITRA(R) (vardenafil HCl), used in treating ED, significantly improves the ability of men with ED and dyslipidemia to achieve and maintain an erection for successful sexual intercourse. These data were presented at the Sexual Medicine Society of North America (SMSNA) Fall Meeting held in Chicago, IL.
Over-The-Counter Solution To Erectile Dysfunction published
Tue, 04 Dec 2007 06:00:00 PDT
For couples worldwide, erectile dysfunction (ED) is one of the leading contributors to a man's inability to perform. As millions of men in America each year look for a solution, many seek alternative treatments to prescription medications and surgery that may have dangerous side effects.
New Patient Research Shows Importance Of Early Success In Treating Erectile Dysfunction published
Thu, 29 Nov 2007 02:00:00 PDT
A UK study, made available at the 10th Congress of the European Society of Sexual Medicine in Lisbon, has warned healthcare professionals who treat erectile dysfunction (ED) of the importance of their first patient consultation.
Innovative Research Into Erectile Dysfunction In Diabetics Rewarded At ESSM Congress published
Thu, 29 Nov 2007 01:00:00 PDT
The fourth annual ESSM Award of Excellence has been awarded to Professors Dr Carla Costa and Dr Pedro Vendeira for their ground-breaking research into erectile dysfunction in diabetics, during the 10th annual ESSM Congress taking place in Lisbon, Portugal. The study, entitled Bone-marrow Derived-cell Treatment for Diabetes-associated Erectile Dysfunction, provides new preliminary answers to erectile dysfunction that occurs earlier on in diabetics.
NexMed Confirms FDA Acceptance Of NDA For Erectle Dysfunction Product published
Wed, 21 Nov 2007 12:00:00 PDT
NexMed, Inc. (Nasdaq: NEXM), a developer of innovative transdermal products based on its proprietary NexACT® drug delivery technology, announced that the New Drug Application (NDA) filed by the Company for its erectile dysfunction (ED) product, a topically applied alprostadil cream, was accepted for review by the U.S. Food and Drug Administration (FDA).
Sciele Pharma And Plethora Solutions Holdings PLC Announce Initiation Of Pivotal Phase III Trials For PSD502 For Premature Ejaculation published
Fri, 02 Nov 2007 04:00:00 PDT
Sciele Pharma, Inc. ("Sciele") (NASDAQ:SCRX), a specialty pharmaceutical company, and Plethora Solutions Holdings PLC ("Plethora") (AIM:PLE), the specialist developer of products for the treatment and management of urological disorders, jointly announced that they have initiated patient enrollment for the Phase III clinical trials in the U.S. for PSD502 for the treatment of premature ejaculation. In May 2007, Sciele signed an exclusive licensing agreement for PSD502 with Plethora Solutions.
Have A Smoke Free Holiday published
Sun, 28 Oct 2007 00:00:00 PDT
Smoking cigarettes causes cancer and increases the risk of cardiovascular and other diseases, but there's even more bad news for men who smoke. They have an increased risk of experiencing erectile dysfunction, and the more cigarettes smoked, the greater the risk, according to a study by Tulane University researchers published in the American Journal of Epidemiology.
FDA Reports Hearing Loss Linked To Viagra And Other PDE5 Inhibitors published
Mon, 22 Oct 2007 03:00:00 PDT
The US Food and Drug Administration (FDA) has received reports of sudden reduction or loss of hearing following the use of PDE5 inhibitors, a class of drugs that includes the erectile dysfunction (ED) medications Viagra, Levitra, and Cialis and also Revatio, used to treat pulmonary arterial hypertension (PAH).
FDA Announces Revisions To Labels For Cialis, Levitra And Viagra published
Fri, 19 Oct 2007 05:00:00 PDT
The U.S. Food and Drug Administration has approved labeling changes for erectile dysfunction (ED) drugs in the class that includes Cialis, Levitra, and Viagra, to display more prominently the potential risk of sudden hearing loss, and to guide consumers on what to do if they experience sudden problems with their hearing.
Diabetes In The Bedroom: Scarier Than Halloween? published
Sat, 06 Oct 2007 14:00:00 PDT
Halloween can be frightening, from the haunted houses to the trick-or-treating ghosts and goblins. But for some, there is something that is much scarier than Halloween: diabetes in the bedroom. Sexual dysfunction is a diabetes complication for both men and women. According to the American Diabetes Association (ADA), fluctuation in hormone and blood glucose levels, depression, and nerve damage all contribute to sexual dysfunction.
Online Treatment Service For Male Impotence To Be Launched By Chelsea And Westminster And DrThom, UK published
Fri, 14 Sep 2007 13:00:00 PDT
Chelsea and Westminster Hospital NHS Foundation Trust becomes the first NHS body to venture into online treatment by launching a remote treatment service for erectile dysfunction in partnership with DrThom (http://www.drthom.com), the UK's leading online healthcare provider. Chelsea and Westminster and DrThom will make it easier for the 2.
)
|
|
